Latest News | Marksans Pharma Gets USFDA Nod for Generic Allergic Rhinitis Treatment Tablets

New Delhi, Nov 22 (PTI) Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Loratadine tablets indicated in the treatment of allergic rhinitis.

The approval by the US Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Loratadine tablets of strength 10 mg, Marksans Pharma said in a regulatory filing.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for November 22, 2024 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

Loratadine tablets are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use. This product is a generic version of Clartin tablet in the same strength as Bayer Healthcare, the company added.

Loratadine is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies, it added.

Also Read | Maharashtra Election Result 2024: Which Parties Are Members of MahaYuti and Maha Vikas Aghadi? How Many Seats Did BJP, Congress, Shiv Sena, NCP, Shiv Sena (UBT) and NCP (SP) Contest in Vidhan Sabha Polls?.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)